Alzheimers Disease Diagnostics Market
According to Intent Market Research, the Alzheimer’s Disease Diagnostics Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 8.0% to touch USD 15.9 billion by 2030. The Alzheimer’s Disease Diagnostics Market is dominated by key players such as Roche Holding AG, Eli Lilly and Co., Biogen Inc., Siemens Healthineers AG, GE Healthcare, Johnson & Johnson, AbbVie Inc., Novartis AG, Medtronic PLC, Philips Healthcare, AstraZeneca, Quanterix Corporation, Corteva Inc., Thermo Fisher Scientific, Mindset Inc.